Topics

Articles

Decision is anticipated to boost operational efficiencies for the CDMO.

KBI Biopharma, Selexis SA Merge as One Organization

Company is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.

WuXi Biologics Expands Manufacturing Capacity in Germany

New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.

Channel Fragmentation and Diversifying Product Archetypes

Company’s latest report reveals future plans, powered by efforts to divert more of its air shipments to sea.

Pharmanovia Unveils Status in Accomplishing Sustainability Goals

New fill-finish plant strengthens nation’s reputation as an APAC biomedical hub.

Thermo Fisher Scientific Opens Sterile Drug Facility in Singapore

Document reveals that 20 of 28 of participating Big Pharma manufacturers saw their DIO increase by an average of 5%, suggesting that large amounts of inventory do not necessarily offer protection from running low on medication.

nVentic Report: Manufacturer Inventories Fail to Prevent Medicine Shortages

The treatments span various therapeutic areas, from antibiotic to oncology.

Sandoz, Adalvo Agree to Exclusively Commercialize Products in the US

New capability will support manufacturing of commercial-stage therapies to help combat cancers and genetic diseases.

Aldevron Expands mRNA Production Capacity

Roundtable drills down on ways the two sectors can come together to reduce carbon emissions.

LogiPharma Europe 2023: Air Freight and Pharma as Key Sustainability Partners

Real-time location monitoring solution allows increased visibility into the precise location of shipments in transit globally.

Manufacturing & Packaging